ARTICLE | Clinical News
Letairis ambrisentan: Phase IV start
November 9, 2009 8:00 AM UTC
Next year, Gilead will start the double-blind, international Phase IV AMBITION trial to compare ambrisentan and tadalafil both alone and in combination as first-line therapy in over 300 patients. Glax...